Autophagy, cell death and sustained senescence arrest in B16/F10 melanoma cells and HCT-116 colon carcinoma cells in response to the novel microtubule poison, JG-03-14

• Published in: Cancer chemotherapy and pharmacology 2013-02, Vol.71 (2), p.441-455
• Main Authors: Biggers, Jonathan W., Nguyen, Tuyen, Di, Xu, Gupton, John T., Henderson, Scott C., Emery, Sean M., Alotaibi, Moureq, White, Kimber L., Brown, Ronetta, Almenara, Jorge, Gewirtz, David A.
• Format: Article
• Language: English
• Subjects: Animals; Antineoplastic agents; Apoptosis - drug effects; Autophagy - drug effects; Biological and medical sciences; Cancer Research; Cellular Senescence - drug effects; Colonic Neoplasms - drug therapy; Colonic Neoplasms - pathology; Dermatology; Gastroenterology. Liver. Pancreas. Abdomen; HCT116 Cells; Humans; Medical sciences; Medicine; Medicine & Public Health; Melanoma, Experimental - drug therapy; Melanoma, Experimental - pathology; Mice; Mice, Inbred BALB C; Microtubules - drug effects; Multiple tumors. Solid tumors. Tumors in childhood (general aspects); Oncology; Original Article; Peripheral Nervous System Diseases - chemically induced; Pharmacology. Drug treatments; Pharmacology/Toxicology; Pyrroles - pharmacology; Pyrroles - toxicity; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus; Tumors; Tumors of the skin and soft tissue. Premalignant lesions
• ISSN: 0344-5704; 1432-0843
• DOI: 10.1007/s00280-012-2024-6

Purpose Previous studies have shown that the novel microtubule poison, JG-03-14, which binds to the colchicine binding site of tubulin, has the capacity to kill breast tumor cells primarily through the promotion of autophagy. The current work was designed to determine whether autophagy was, in fact, the primary mode of action as well as susceptibility to JG-03-14 in two additional tumor cell models, the B16/F10 murine melanoma cell line and the HCT-116 human colon cancer cell line. Methods Drug cytotoxicity was monitored based on viable cell number and clonogenic survival. Apoptosis was assessed by DAPI staining, the TUNEL assay and/or FACS analysis. Autophagy was monitored based on staining with acridine orange, redistribution and punctuation of RFP-LC3 and electron microscopy as well as p62 degradation. Senescence was evaluated based on β-galactosidase staining and alterations in cell morphology. Drug effects were also evaluated in a murine model of B16/F10 cells that localizes to the lungs while peripheral neuropathy was assessed by three complementary behavioral assays. Results Both HCT-116 colon cancer cells and B16/F10 melanoma cells were sensitive to JG-03-14 in that the drug demonstrated tumor cell killing. However, there was minimal induction of apoptosis. In contrast, there was clear evidence for autophagy and autophagic flux while the residual surviving cells appeared to be in a state of irreversible senescence. Inhibition of drug-induced autophagy in either the melanoma cells or the colon carcinoma cells was only slightly protective as the cells instead died by apoptosis. JG-03-14 reduced the size of tumor nodules in mice lungs; furthermore, the drug did not promote peripheral neuropathy. Conclusions Taken together with evidence for its actions as a vascular disrupting agent, these observations support the potential utility of JG-03-14 to effectively treat malignancies that might be resistant to conventional chemotherapy through evasion of apoptosis.